From: Benefit of adjuvant chemotherapy in patients with T4 UICC II colon cancer
Group comparisons | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FUFOL | FUFOL + Oxaliplatin | Others + Oxaliplatin | Other substances | Substance unknown | No chemotherapy | ||||||||
Chemotheraphy | Chi- | Chi- | Chi- | Chi- | Chi- | Chi- | |||||||
group | square | Sig. | square | Sig. | square | Sig. | square | Sig. | square | Sig. | square | Sig. | |
Long Rank | FUFOL | ,072 | ,788 | . | . | ,013 | ,909 | ,563 | ,453 | 4,179 | ,041 | ||
(Mantel-Cox) | FUFOL + Oxaliplatin | ,072 | ,788 | ,074 | ,785 | ,192 | ,661 | ,015 | ,901 | 3,934 | ,047 | ||
Others + Oxaliplatin | . | . | ,074 | ,785 | ,118 | ,732 | . | . | ,628 | ,428 | |||
Other substances | ,013 | ,909 | ,192 | ,661 | ,118 | ,732 | ,223 | ,636 | 4,370 | ,037 | |||
Substance unknown | ,563 | ,453 | ,015 | ,901 | ,223 | ,636 | ,681 | ,409 | |||||
No chemotheraphy | 4,179 | ,041 | 3,934 | ,047 | ,628 | ,428 | 4,370 | ,037 | ,681 | ,409 |